MedTrace Logo

A Study on the Correlation Between Interleukin 28B Genotypes With Clinical and Demographic Characteristics in Treatment-Naïve and Treatment-Experienced Patients With Chronic Hepatitis C

NCT01675427 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4766

Last updated 2015-08-26

Study results available
· View outcomes & findings →

Summary

This multicenter study will evaluate the correlation of interleukin 28B (IL28B) genotypes with disease characteristics and demographics in treatment-naïve and treatment-experienced chronic hepatitis C patients, including patients with HIV co-infection. There will be a single study visit for testing.

Conditions

  • Hepatitis C, Chronic

Interventions

OTHER

Interleukin 28B testing

Blood sampling for ILB28 genotyping

Sponsors & Collaborators

Principal Investigators

  • Clinical Trials · Hoffmann-La Roche

Study Design

Allocation
NON_RANDOMIZED
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2013-10-31
Completion
2013-10-31

Countries

  • United States
  • Argentina
  • Belgium
  • Chile
  • Egypt
  • Estonia
  • France
  • Germany
  • Greece
  • Italy
  • Kuwait
  • Latvia
  • Lebanon
  • Lithuania
  • Mexico
  • North Macedonia
  • Oman
  • Pakistan
  • Peru
  • Portugal
  • Qatar
  • Romania
  • Serbia
  • Slovakia
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Turkey (Türkiye)
  • United Arab Emirates
  • Venezuela

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01675427 on ClinicalTrials.gov